Compile Data Set for Download or QSAR
Report error Found 96 Enz. Inhib. hit(s) with all data for entry = 9120
TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443131BDBM443131(US10654833, Compound 5)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443190BDBM443190(US10654833, Compound 102)
Affinity DataIC50: 0.700nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443127BDBM443127(US10654833, Compound 1)
Affinity DataKd:  0.75nMAssay Description:Compound binding to the ASK1 kinase active site was determined using the KINOMEscan Assay platform (DiscoverX, San Diego, Calif.). Briefly, ASK1-tagg...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443140BDBM443140(US10654833, Compound 39 | US10654833, Compound 67)
Affinity DataKd:  0.860nMAssay Description:Compound binding to the ASK1 kinase active site was determined using the KINOMEscan Assay platform (DiscoverX, San Diego, Calif.). Briefly, ASK1-tagg...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443135BDBM443135(US10654833, Compound 13)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443199BDBM443199(US10654833, Compound 113)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443174BDBM443174(US10654833, Compound 86)
Affinity DataIC50: 1.83nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443203BDBM443203(US10654833, Compound 117)
Affinity DataIC50: 1.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443200BDBM443200(US10654833, Compound 114)
Affinity DataIC50: 2.10nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443175BDBM443175(US10654833, Compound 87)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443142BDBM443142(US10654833, Compound 53)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443218BDBM443218(US10654833, Compound 37)
Affinity DataIC50: 2.80nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443165BDBM443165(US10654833, Compound 77)
Affinity DataIC50: 2.80nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443170BDBM443170(US10654833, Compound 82)
Affinity DataIC50: 3.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443189BDBM443189(US10654833, Compound 101)
Affinity DataIC50: 3.28nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443140BDBM443140(US10654833, Compound 39 | US10654833, Compound 67)
Affinity DataIC50: 3.30nMAssay Description:Compound binding to the ASK1 kinase active site was determined using the KINOMEscan Assay platform (DiscoverX, San Diego, Calif.). Briefly, ASK1-tagg...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443140BDBM443140(US10654833, Compound 39 | US10654833, Compound 67)
Affinity DataIC50: 3.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443183BDBM443183(US10654833, Compound 95)
Affinity DataIC50: 3.40nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443209BDBM443209(US10654833, Compound 123)
Affinity DataIC50: 3.5nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443173BDBM443173(US10654833, Compound 85)
Affinity DataIC50: 3.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443208BDBM443208(US10654833, Compound 122)
Affinity DataIC50: 3.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443139BDBM443139(US10654833, Compound 35)
Affinity DataIC50: 4nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443207BDBM443207(US10654833, Compound 121)
Affinity DataIC50: 4.10nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443128BDBM443128(US10654833, Compound 2)
Affinity DataIC50: 4.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443159BDBM443159(US10654833, Compound 71)
Affinity DataIC50: 4.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443172BDBM443172(US10654833, Compound 84)
Affinity DataIC50: 4.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443178BDBM443178(US10654833, Compound 90)
Affinity DataIC50: 4.40nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443202BDBM443202(US10654833, Compound 116)
Affinity DataIC50: 4.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443166BDBM443166(US10654833, Compound 78)
Affinity DataIC50: 4.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443167BDBM443167(US10654833, Compound 79)
Affinity DataIC50: 4.60nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443141BDBM443141(US10654833, Compound 41)
Affinity DataIC50: 4.70nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443160BDBM443160(US10654833, Compound 72)
Affinity DataIC50: 4.70nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443185BDBM443185(US10654833, Compound 97)
Affinity DataIC50: 4.70nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443177BDBM443177(US10654833, Compound 89)
Affinity DataIC50: 4.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443129BDBM443129(US10654833, Compound 3)
Affinity DataIC50: 4.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443176BDBM443176(US10654833, Compound 88)
Affinity DataIC50: 4.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443186BDBM443186(US10654833, Compound 98)
Affinity DataIC50: 4.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443184BDBM443184(US10654833, Compound 96)
Affinity DataIC50: 4.90nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443148BDBM443148(US10654833, Compound 60)
Affinity DataIC50: 5nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443146BDBM443146(US10654833, Compound 58)
Affinity DataIC50: 5.10nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443149BDBM443149(US10654833, Compound 61)
Affinity DataIC50: 5.10nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443151BDBM443151(US10654833, Compound 63)
Affinity DataIC50: 5.10nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443196BDBM443196(US10654833, Compound 108)
Affinity DataIC50: 5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443195BDBM443195(US10654833, Compound 107)
Affinity DataIC50: 5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443127BDBM443127(US10654833, Compound 1)
Affinity DataIC50: 5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443205BDBM443205(US10654833, Compound 119)
Affinity DataIC50: 5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443127BDBM443127(US10654833, Compound 1)
Affinity DataIC50: 5.20nMAssay Description:Compound binding to the ASK1 kinase active site was determined using the KINOMEscan Assay platform (DiscoverX, San Diego, Calif.). Briefly, ASK1-tagg...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443168BDBM443168(US10654833, Compound 80)
Affinity DataIC50: 5.20nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443147BDBM443147(US10654833, Compound 59)
Affinity DataIC50: 5.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

TargetMitogen-activated protein kinase kinase kinase 5(Human)
Hepatikos Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 443137BDBM443137(US10654833, Compound 20)
Affinity DataIC50: 5.30nMAssay Description:Inhibition of ASK1 kinase activity was determined radiometrically using 33P substrate incorporation (Reaction Biology Corp., Malvern, Pa.). Briefly, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/1/2021
Entry Details
US Patent

Displayed 1 to 50 (of 96 total ) | Next | Last >>
Jump to: